arrow
S

Shane Nanayakkara

Alfred Hospital
H指数:27
被引数:2,783

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exercise stress echocardiography for diagnosis of heart failure with preserved ejection fraction: a multicentre study

运动负荷超声心动图对射血分数保留的心力衰竭的诊断:一项多中心研究

2026-09-100
PRE
CA in AF With LVSD With and Without LV Fibrosis

左心室收缩功能障碍伴或不伴有左心室纤维化的房颤患者中的CA

2026-06-040
PRE
Beta-blocker therapy and all-cause mortality after a coronary event: A matched nested case-control study using the Victorian Cardiac Outcomes Registry linked data

β受体阻滞剂治疗与冠状动脉事件后的全因死亡率:一项基于维多利亚心脏结局登记处关联数据的配对巢式病例对照研究

2026-04-030
OAAI
Echocardiographic Diastolic Function Grading in HFpEF

超声心动图舒张功能分级在HFpEF中的应用

JACC
IF0
2026-01-140
PRE
Withdrawal of heart failure therapy after atrial fibrillation rhythm control with ejection fraction normalization: the WITHDRAW-AF trial

射血分数正常化后心房颤动节律控制的心力衰竭疗法撤药:WITHDRAW-AF试验

2025-08-013
OA
Catheter ablation vs rate control in atrial fibrillation with left ventricular systolic dysfunction and fibrosis: the CAMERA-MRI II trial

导管消融与心率控制在左心室收缩功能不全和纤维化的心房颤动中的比较:CAMERA-MRI II试验

2025-08-011
OAAI
Impact of Mitral Regurgitation on Outcomes of Catheter Ablation for AF With Left Ventricular Systolic Dysfunction

二尖瓣反流对左心室收缩功能不全的心房颤动导管消融结局的影响

2025-04-240
PRE
Routine Protamine Administration for Bleeding in Transcatheter Aortic Valve Implantation: The ACE-PROTAVI Randomized Clinical Trial
2024-10-011
PRE